In accordance with this hypothesis is the fact that genetic invalidation of the cystine transporter (xCT), as well as the serine transporter (ASCT2), in cancer cells leads to reduced/delayed tumor growth, while no effect has been observed in xCT or ASCT2 null mice under physiological conditions [49,73,78]. The gene discussed is SLC7A11; the disease is cancer.